Evidence map›Paper›PMID 37860838›Full record

ArticleEMBO reports2023

Cytotoxic T lymphocytes require transcription for infiltration but not target cell lysis.

Arianne C Richard, Claire Y Ma, John C Marioni, Gillian M Griffiths

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Arianne C RichardCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0002-8708-9997
Claire Y MaCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4244-7535
John C MarioniCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9092-0852
Gillian M GriffithsCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0434-5842
University of Cambridge · GBEuropean Bioinformatics Institute · GB

Funding

Cancer Research UK A17197Medical Research Council MR/P014178/1Wellcome TrustWellcome Trust 217100Wellcome Trust 220543
6 · The paper itself

Abstract

Effector cytotoxic T lymphocytes (CTLs) are critical for ridding the body of infected or cancerous cells. CTL T cell receptor (TCR) ligation not only drives the delivery and release of cytolytic granules but also initiates a new wave of transcription. In order to address whether TCR-induced transcriptomic changes impact the ability of CTLs to kill, we asked which genes are expressed immediately after CTLs encounter targets and how CTL responses change when inhibiting transcription. Our data demonstrate that while expression of cytokines/chemokines and transcriptional machinery depend on transcription, cytotoxic protein expression and cytolytic activity are relatively robust to transcription blockade, with CTLs lysing nearby target cells for several hours after actinomycin D treatment. Monitoring CTL movement among target cells after inhibiting transcription demonstrates an infiltration defect that is not rectified by provision of exogenous cytokine/chemokine gradients, indicating a cell-intrinsic transcriptional requirement for infiltration. Together, our results reveal differential molecular control of CTL functions, separating recruitment and infiltration from cytolysis.

Indexed as

CytokinesT-Lymphocytes, CytotoxicReceptors, Antigen, T-CellCytokinesReceptors, Antigen, T-Cellchemotaxiscytolysiscytotoxic T cellinfiltrationtranscription

Identifiers

PMID37860838
PMCPMC10626425
OpenAlexW4387798203

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.